News

Article

Pharmaceutical Technology

Pharmaceutical Technology-05-15-2020
Volume2020 eBook
Issue 2
Pages: 10–14, 43

Complications in Process Simulation Execution

Regulators have exaggerated expectations for simulated media fills.

Regulators have exaggerated expectations for simulated media fills.

This article reviews aspects of media fill execution in which regulatory expectations have created artificial compliance concerns and significant practical difficulties.

 

Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing eBook.

Article Details

Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing
May 2020
Pages: 10–14, 43

Citation

When referring to this article, please cite it as J. Agalloco, "Complications in Process Simulation Execution," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Behind the Headlines, Episode 18
Related Content